Porras TB - Search Results

1

Circulating Tumor Cell Transcriptomics as Biopsy Surrogates in Metastatic Breast Cancer.

Ring A, Campo D, Porras TB, Kaur P, Forte VA, Tripathy D, Lu J, Kang I, Press MF, Jeong YJ, Snow A, Zhu Y, Zada G, Wagle N, Lang JE. Ring A, et al. Among authors: porras tb. Ann Surg Oncol. 2022 May;29(5):2882-2894. doi: 10.1245/s10434-021-11135-2. Epub 2022 Jan 9. Ann Surg Oncol. 2022. PMID: 35000083 Free PMC article.

2

EpCAM based capture detects and recovers circulating tumor cells from all subtypes of breast cancer except claudin-low.

Ring A, Mineyev N, Zhu W, Park E, Lomas C, Punj V, Yu M, Barrak D, Forte V, Porras T, Tripathy D, Lang JE. Ring A, et al. Oncotarget. 2015 Dec 29;6(42):44623-34. doi: 10.18632/oncotarget.5977. Oncotarget. 2015. PMID: 26556851 Free PMC article.

3

Challenges in using liquid biopsies for gene expression profiling.

Porras TB, Kaur P, Ring A, Schechter N, Lang JE. Porras TB, et al. Oncotarget. 2018 Jan 11;9(6):7036-7053. doi: 10.18632/oncotarget.24140. eCollection 2018 Jan 23. Oncotarget. 2018. PMID: 29467948 Free PMC article.

4

RNA-Seq of Circulating Tumor Cells in Stage II-III Breast Cancer.

Lang JE, Ring A, Porras T, Kaur P, Forte VA, Mineyev N, Tripathy D, Press MF, Campo D. Lang JE, et al. Ann Surg Oncol. 2018 Aug;25(8):2261-2270. doi: 10.1245/s10434-018-6540-4. Epub 2018 Jun 4. Ann Surg Oncol. 2018. PMID: 29868978 Free PMC article.

5

Comparison of TCGA and GENIE genomic datasets for the detection of clinically actionable alterations in breast cancer.

Kaur P, Porras TB, Ring A, Carpten JD, Lang JE. Kaur P, et al. Among authors: porras tb. Sci Rep. 2019 Feb 6;9(1):1482. doi: 10.1038/s41598-018-37574-8. Sci Rep. 2019. PMID: 30728399 Free PMC article.

6

A Pilot Study for the Feasibility of Exome-Sequencing in Circulating Tumor Cells Versus Single Metastatic Biopsies in Breast Cancer.

Kaur P, Campo D, Porras TB, Ring A, Lu J, Chairez Y, Su Y, Kang I, Lang JE. Kaur P, et al. Among authors: porras tb. Int J Mol Sci. 2020 Jul 8;21(14):4826. doi: 10.3390/ijms21144826. Int J Mol Sci. 2020. PMID: 32650480 Free PMC article.

7

Identification of putative actionable alterations in clinically relevant genes in breast cancer.

Kaur P, Porras TB, Colombo A, Ring A, Lu J, Kang I, Lang JE. Kaur P, et al. Among authors: porras tb. Br J Cancer. 2021 Oct;125(9):1270-1284. doi: 10.1038/s41416-021-01522-7. Epub 2021 Aug 28. Br J Cancer. 2021. PMID: 34455425 Free PMC article.

8

Correction to: Circulating Tumor Cell Transcriptomics as Biopsy Surrogates in Metastatic Breast Cancer.

Ring A, Campo D, Porras TB, Kaur P, Forte VA, Tripathy D, Lu J, Kang I, Press MF, Jeong YJ, Snow A, Zhu Y, Zada G, Wagle N, Lang JE. Ring A, et al. Among authors: porras tb. Ann Surg Oncol. 2022 May;29(5):3064. doi: 10.1245/s10434-022-11589-y. Ann Surg Oncol. 2022. PMID: 35258770 Free PMC article. No abstract available.

9

Integrated Proteogenomic Analysis Reveals Distinct Potentially Actionable Therapeutic Vulnerabilities in Triple-Negative Breast Cancer Subtypes.

Kaur P, Ring A, Porras TB, Zhou G, Lu J, Kang I, Lang JE. Kaur P, et al. Among authors: porras tb. Cancers (Basel). 2024 Jan 25;16(3):516. doi: 10.3390/cancers16030516. Cancers (Basel). 2024. PMID: 38339267 Free PMC article.

10

Forced LIGHT expression in prostate tumors overcomes Treg mediated immunosuppression and synergizes with a prostate tumor therapeutic vaccine by recruiting effector T lymphocytes.

Yan L, Da Silva DM, Verma B, Gray A, Brand HE, Skeate JG, Porras TB, Kanodia S, Kast WM. Yan L, et al. Among authors: porras tb. Prostate. 2015 Feb 15;75(3):280-91. doi: 10.1002/pros.22914. Epub 2014 Nov 14. Prostate. 2015. PMID: 25399517 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

16 results

Search Page